Biocryst Pharmaceuticals (BCRX) Prepaid Assets (2010 - 2026)

Biocryst Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $19.1 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 33.41% year-over-year to $19.1 million; the trailing twelve-month figure through Mar 2026 stood at $19.1 million (up 33.41% YoY), and the FY2025 full-year result was $17.2 million, up 24.94% from the prior year.
• Prepaid Assets for Q1 2026 stood at $19.1 million, up from $17.2 million in the prior quarter.
• The five-year high for Prepaid Assets was $20.0 million in Q3 2023, with the low at $11.1 million in Q2 2022.
• Historically, Prepaid Assets has averaged $15.3 million across 5 years, with a median of $15.2 million in 2023.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 108.75% — and 2024, when it declined 29.63%.
• Biocryst Pharmaceuticals' Prepaid Assets stood at $12.6 million in 2022, then soared by 55.27% to $19.5 million in 2023, then decreased by 29.63% to $13.8 million in 2024, then rose by 24.94% to $17.2 million in 2025, then increased by 11.24% to $19.1 million in 2026.
• The last three Prepaid Assets figures came in at $19.1 million (Q1 2026), $17.2 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.